AddLife AB (publ) (ALIF-B.ST)

SEK 189.0

(3.28%)

EBITDA Summary of AddLife AB (publ)

AddLife AB (publ)'s latest annual EBITDA in 2023 was 1.54 Billion SEK , up 1.67% from previous year.
AddLife AB (publ)'s latest quarterly EBITDA in 2024 Q2 was 390 Million SEK , up 1.56% from previous quarter.
AddLife AB (publ) reported an annual EBITDA of 1.45 Billion SEK in 2022, down -1.73% from previous year.
AddLife AB (publ) reported an annual EBITDA of 1.46 Billion SEK in 2021, up 54.25% from previous year.
AddLife AB (publ) reported a quarterly EBITDA of 114 Million SEK for 2024 Q3, down -70.77% from previous quarter.
AddLife AB (publ) reported a quarterly EBITDA of 385 Million SEK for 2024 Q1, down -14.67% from previous quarter.

Annual EBITDA Chart of AddLife AB (publ) (2023 - 2012)

Historical Annual EBITDA of AddLife AB (publ) (2023 - 2012)

Year	EBITDA	EBITDA Growth
2023	1.54 Billion SEK	1.67%
2022	1.45 Billion SEK	-1.73%
2021	1.46 Billion SEK	54.25%
2020	951 Million SEK	121.34%
2019	428 Million SEK	62.02%
2018	264.8 Million SEK	4.19%
2017	254.4 Million SEK	27.56%
2016	206.7 Million SEK	35.31%
2015	150.3 Million SEK	-11.57%
2014	130.3 Million SEK	28.11%
2013	128.1 Million SEK	-0.54%
2012	130.5 Million SEK	0.0%

Year	EBITDA	EBITDA Growth
2024 Q2	390 Million SEK	1.56%
2024 Q3	114 Million SEK	-70.77%
2024 Q1	385 Million SEK	-14.67%
2023 Q1	258 Million SEK	369.09%
2023 Q3	132 Million SEK	-2.94%
2023 Q2	136 Million SEK	-47.29%
2023 FY	- SEK	1.67%
2023 Q4	450 Million SEK	240.91%
2022 Q4	55 Million SEK	-69.95%
2022 Q2	138 Million SEK	-59.17%
2022 Q1	338 Million SEK	45.0%
2022 FY	- SEK	-1.73%
2022 Q3	183 Million SEK	32.61%
2021 Q4	233.1 Million SEK	12.61%
2021 FY	- SEK	54.25%
2021 Q1	291 Million SEK	3.19%
2021 Q2	253 Million SEK	-13.06%
2021 Q3	207 Million SEK	-18.18%
2020 FY	- SEK	121.34%
2020 Q4	282 Million SEK	66.86%
2020 Q3	169 Million SEK	11.92%
2020 Q2	151 Million SEK	104.05%
2020 Q1	74 Million SEK	3.21%
2019 Q4	71.7 Million SEK	99.17%
2019 Q1	45 Million SEK	-13.79%
2019 Q3	36 Million SEK	-14.29%
2019 Q2	42 Million SEK	-6.67%
2019 FY	- SEK	62.02%
2018 Q2	43 Million SEK	10.26%
2018 FY	- SEK	4.19%
2018 Q4	52.2 Million SEK	68.39%
2018 Q3	31 Million SEK	-27.91%
2018 Q1	39 Million SEK	-34.56%
2017 Q2	40 Million SEK	0.0%
2017 FY	- SEK	27.56%
2017 Q3	26 Million SEK	-35.0%
2017 Q1	40 Million SEK	-37.79%
2017 Q4	59.6 Million SEK	129.23%
2016 Q2	36.5 Million SEK	110.98%
2016 Q3	21.3 Million SEK	-41.64%
2016 Q1	17.3 Million SEK	-48.51%
2016 Q4	64.3 Million SEK	201.88%
2016 FY	- SEK	35.31%
2015 FY	- SEK	-11.57%
2015 Q3	16.6 Million SEK	-44.48%
2015 Q4	33.6 Million SEK	102.41%
2015 Q1	62.1 Million SEK	79.48%
2015 Q2	29.9 Million SEK	-51.85%
2014 FY	- SEK	28.11%
2014 Q4	34.6 Million SEK	0.0%
2013 FY	- SEK	-0.54%
2012 FY	- SEK	0.0%

Peer EBITDA Comparison of AddLife AB (publ)

Name	EBITDA	EBITDA Difference
Biotage AB (publ)	432 Million SEK	-257.87%
Bonesupport Holding AB (publ)	28.93 Million SEK	-5242.641%
Doxa AB (publ)	296 Million SEK	-422.297%
Elekta AB (publ)	3.29 Billion SEK	53.023%
iZafe Group AB (publ)	-15.61 Million SEK	9999.469%
Ortivus AB (publ)	-14.92 Million SEK	10457.765%
Ortivus AB (publ)	-14.92 Million SEK	10457.765%
Q-linea AB (publ)	-210.98 Million SEK	832.75%
S2Medical AB (publ)	-13.52 Million SEK	11527.198%
Synsam AB (publ)	1.71 Billion SEK	9.643%